Skip to content
Adrienne Monson – Lifestyle
Author:
ORIC Pharmaceuticals
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
May 27, 2026
ORIC® Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Updates
May 4, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 1, 2026
←
Previous Page
1
2